The insulin-like growth factor 1 receptor (IGF-1R) is frequently overexpressed in osteosarcoma, contributing to enhanced cell proliferation and survival through the activation of downstream signaling pathways, including the PI3K/Akt and MAPK pathways [183]. Here, IGF1R is linked to osteosarcoma.